Cargando…
Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris
BACKGROUND: Excess levels of serum acylcarnitines, which are intermediate products in metabolism, have been observed in metabolic diseases such as type 2 diabetes mellitus. However, it is not known whether acylcarnitines may prospectively predict risk of cardiovascular death or acute myocardial infa...
Autores principales: | Strand, Elin, Pedersen, Eva R., Svingen, Gard F. T., Olsen, Thomas, Bjørndal, Bodil, Karlsson, Therese, Dierkes, Jutta, Njølstad, Pål R., Mellgren, Gunnar, Tell, Grethe S., Berge, Rolf K., Svardal, Asbjørn, Nygård, Ottar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523736/ https://www.ncbi.nlm.nih.gov/pubmed/28159823 http://dx.doi.org/10.1161/JAHA.116.003620 |
Ejemplares similares
-
Plasma Cystathionine and Risk of Incident Stroke in Patients With Suspected Stable Angina Pectoris
por: Dhar, Indu, et al.
Publicado: (2018) -
Fish Oil and the Pan-PPAR Agonist Tetradecylthioacetic Acid Affect the Amino Acid and Carnitine Metabolism in Rats
por: Bjørndal, Bodil, et al.
Publicado: (2013) -
Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris
por: Ding, Yunpeng, et al.
Publicado: (2015) -
Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease
por: Storesund, Silje Kjellevold, et al.
Publicado: (2022) -
Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment
por: Dhar, Indu, et al.
Publicado: (2022)